A detailed history of Cullen/Frost Bankers, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 3,717 shares of VTRS stock, worth $48,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,717
Previous 4,548 18.27%
Holding current value
$48,321
Previous $48,000 10.42%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$10.32 - $12.13 $8,575 - $10,080
-831 Reduced 18.27%
3,717 $43,000
Q2 2024

Aug 05, 2024

BUY
$10.05 - $12.02 $572 - $685
57 Added 1.27%
4,548 $48,000
Q1 2024

May 10, 2024

BUY
$11.27 - $13.53 $833 - $1,001
74 Added 1.68%
4,491 $53,000
Q4 2023

Feb 06, 2024

SELL
$8.77 - $10.85 $18,978 - $23,479
-2,164 Reduced 32.88%
4,417 $47,000
Q3 2023

Nov 02, 2023

BUY
$9.59 - $11.35 $3,778 - $4,471
394 Added 6.37%
6,581 $64,000
Q2 2023

Aug 04, 2023

SELL
$9.02 - $10.29 $8,478 - $9,672
-940 Reduced 13.19%
6,187 $61,000
Q1 2023

May 05, 2023

BUY
$9.2 - $12.26 $23,220 - $30,944
2,524 Added 54.83%
7,127 $68,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $2,118 - $2,809
-243 Reduced 5.01%
4,603 $51,000
Q3 2022

Nov 07, 2022

BUY
$8.48 - $11.13 $839 - $1,101
99 Added 2.09%
4,846 $41,000
Q2 2022

Aug 05, 2022

SELL
$9.95 - $12.27 $6,935 - $8,552
-697 Reduced 12.8%
4,747 $50,000
Q1 2022

May 09, 2022

BUY
$9.81 - $15.4 $1,491 - $2,340
152 Added 2.87%
5,444 $59,000
Q4 2021

Feb 07, 2022

SELL
$12.09 - $14.68 $34,553 - $41,955
-2,858 Reduced 35.07%
5,292 $72,000
Q3 2021

Nov 04, 2021

SELL
$13.25 - $15.13 $20,709 - $23,648
-1,563 Reduced 16.09%
8,150 $110,000
Q2 2021

Aug 05, 2021

SELL
$12.97 - $16.15 $30,583 - $38,081
-2,358 Reduced 19.53%
9,713 $139,000
Q1 2021

May 05, 2021

SELL
$13.59 - $18.54 $47,198 - $64,389
-3,473 Reduced 22.34%
12,071 $169,000
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $222,279 - $291,294
15,544 New
15,544 $291,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.